These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29261493)

  • 1. [Mathematical modeling: an essential tool for the study of therapeutic targeting in solid tumors].
    Saidak Z; Giacobbi AS; Morisse MC; Mammeri Y; Galmiche A
    Med Sci (Paris); 2017 Dec; 33(12):1055-1062. PubMed ID: 29261493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing the clinical picture of challenging tumors: tales becoming reality?
    Moulin C; Metzger-Filho O; Awada A
    Future Oncol; 2009 Aug; 5(6):785-802. PubMed ID: 19663729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
    Moretti L; Yang ES; Kim KW; Lu B
    Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical modeling analysis of intratumoral disposition of anticancer agents and drug delivery systems.
    Popilski H; Stepensky D
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):767-84. PubMed ID: 25813659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network-based approaches for drug response prediction and targeted therapy development in cancer.
    Dorel M; Barillot E; Zinovyev A; Kuperstein I
    Biochem Biophys Res Commun; 2015 Aug; 464(2):386-91. PubMed ID: 26086105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical modeling in cancer drug discovery.
    Wang Z; Deisboeck TS
    Drug Discov Today; 2014 Feb; 19(2):145-50. PubMed ID: 23831857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Exploiting functional dependencies in cancer cells for the development of targeted therapies].
    Stolze B; Scholl C
    Dtsch Med Wochenschr; 2013 Jun; 138(25-26):1369-72. PubMed ID: 23761060
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.
    Zarei O; Benvenuti S; Ustun-Alkan F; Hamzeh-Mivehroud M; Dastmalchi S
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2429-2446. PubMed ID: 27503093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
    Cojoc M; Mäbert K; Muders MH; Dubrovska A
    Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerating safe drug development: an ideal approach to approval.
    Grever MR
    Hematology Am Soc Hematol Educ Program; 2013; 2013():24-9. PubMed ID: 24319158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disassembling a cancer puzzle: Cell junctions and plasma membrane as targets for anticancer therapy.
    Shilova ON; Shilov ES; Lieber A; Deyev SM
    J Control Release; 2018 Sep; 286():125-136. PubMed ID: 30030181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubulin: an example of targeted chemotherapy.
    Seligmann J; Twelves C
    Future Med Chem; 2013 Mar; 5(3):339-52. PubMed ID: 23464522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cancer with kinase inhibitors.
    Gross S; Rahal R; Stransky N; Lengauer C; Hoeflich KP
    J Clin Invest; 2015 May; 125(5):1780-9. PubMed ID: 25932675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered bifunctional proteins and stem cells: next generation of targeted cancer therapeutics.
    Choi SH; Shah K
    Discov Med; 2016 Sep; 22(120):157-166. PubMed ID: 27755970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vertical pathway targeting in cancer therapy.
    Shahbazian D; Sznol J; Kluger HM
    Adv Pharmacol; 2012; 65():1-26. PubMed ID: 22959021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Zinc(II) Signalling to Prevent Cancer.
    Ziliotto S; Ogle O; Taylor KM
    Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.